Hetero Drugs
HETERO 由Dr. B. P. S. Reddy 与技术专家队创立于1993年，并迅速在印度制药行业跻身前十位，是一家综合性的制药公司，具有完善的研发、生产和销售体系，从事中间体的开发和生产,原料药（API）和成品制剂，拥有全球认可的生产设施，在国际市场上占有一席之地。

　　Hetero在海德拉巴以及周边地区有9个原料药设施，迄今为止有200多种原料药在市场上供应，是抗逆转录病毒药（包括原料药和成品）的最大生产商，是印度市场上最大的成品制剂的合同生产商，现已生产了超过250项产品，包括360亿片剂及5亿胶囊，不同程度上占据着印度本土市场，在印度众制药公司中属于成品制剂的名牌生产商。

　　Hetero拥有强大的研发平台------40个实验室和350位科学家的世界级的研究中心，在Hetero研究基地有不止200种先进的原料药先进的工序，平均每年有15种原料药和40种中间体从研发中心转移到生产再供应于全球不同的市场。

　　Hetero共有员工7000人（其中包括研发人员350位，化学家和工程师3500位）负责承办原料药、中间体和成品制剂的OEM生产，提供完善的原料药和成品制剂。在2010年全球销售额为8亿美金，中国地区采购额为6700万美金。

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs.

Hetero is building on the strengths of vertical integration in discovery research, process chemistry, API manufacturing, formulation development and commercialization. Hetero is a leading international supplier with a rich portfolio of over 200 products from wide range of therapeutic categories both in active pharmaceutical ingredients and finished dosages.

Hetero’s manufacturing facilities are cGMP compliant meeting global standards in terms of infrastructure and systems. Majority of them are approved by the various regulatory authorities of USFDA, WHO-Geneva, Australian TGA, Spanish agency of medicines & health care products, ANVISA-Brazil, IDA-Netherlands etc.,

With full-fledged marketing capabilities, the company has been able to market its products in over 138 countries across the globe.